MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-KL-04-0009940
Emmarlinkpharma Private Limited - pharma in Kannur, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹80.63 Cr
▲ 7% YoY
Net profit · FY 2025
₹14.07 Lakh
Net margin 0.2%
EBITDA · FY 2025
₹1.52 Cr
EBITDA margin 1.9%
Authorised capital
₹7.3 Cr
Registered with MCA
Paid-up capital
₹6.41 Cr
Issued & subscribed
Open charges
₹18.02 Cr
Satisfied ₹35.27 Cr
Company age
7 yrs
Est. 2019
Employees · EPFO
10
Provident fund records
About Emmarlinkpharma Private Limited
Data last updated:
Emmarlinkpharma Private Limited is a private limited company based in Kannur, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74999KL2019PTC057236. Its GSTIN is 32AAFCE4185N1ZD (Kerala). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹7.3 Cr and a paid-up capital of ₹6.41 Cr. It is led by directors including Ramakrishnan Makuni Varayil and Makkuni Amritha Ramakrishnan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Building No. 52/5287 Haji Building Fort Road, Kannur, Kerala, India – 670001.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.63 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹14.07 Lakh (net margin 0.2%) and EBITDA of ₹1.52 Cr (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 67% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹18.02 Cr and satisfied charges of ₹35.27 Cr on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.4 Cr; the latest was in March 2021. Its 10 peer companies in the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 5 smaller; the largest is Abm International Limited with revenue of ₹80.7 Cr.
Emmarlinkpharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-04-0009940). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website emmarlink.com.
Company details
CIN U74999KL2019PTC057236
Registration Number 057236
Incorporation Date 19 March 2019
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KL-04-0009940
Key People
Ramakrishnan Makuni Varayil Director Makkuni Amritha Ramakrishnan Director Praveen Damodar Director Recognitions & Rankings of Emmarlinkpharma
Contact details
Emmarlinkpharma Private Limited's registered office is in Kannur, Kerala. Its website is emmarlink.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBuilding No. 52/5287 Haji Building Fort Road, Kannur, Kerala, India – 670001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Emmarlinkpharma Private Limited, buy the company report.
Comprehensive company report
Emmarlinkpharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Emmarlinkpharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Emmarlinkpharma Private Limited, buy the company report.
Financials of Emmarlinkpharma Private Limited
FY 2025 filings availableEmmarlinkpharma Private Limited reported revenue of ₹80.63 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹80.63 Cr ▲ 7%
Net profit · FY 2025
₹14.07 Lakh margin 0.2%
EBITDA · FY 2025
₹1.52 Cr margin 1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 10%
5 years · compounded
▲ 67%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 10%
5 years · compounded
▲ 93%
Revenue has grown at a compounded annual rate (CAGR) of 67% over five years, including 7% growth in the latest year. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.52 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emmarlinkpharma Private Limited, buy the company report.
Board of directors of Emmarlinkpharma Private Limited
Emmarlinkpharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramakrishnan Makuni Varayil | Director | 24 Jan 2022 | 4 Years 9 Months | Current |
| Makkuni Amritha Ramakrishnan | Director | 19 Mar 2019 | 7 Years 7 Months | Current |
| Praveen Damodar Also directs: Emmar Drug Links Private Limited, Kanhangad Links Private Limited | Director | 19 Mar 2019 | 7 Years 7 Months | Current |
| Aishwarya Praveen | Director | 19 Mar 2019 | 7 Years 7 Months | Current |
| Girija Ramakrishnan | Director | 19 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Emmarlinkpharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abm International Limited | ₹80.7 Cr (FY 2025) | -14.0% | New Delhi, Delhi, India | |||
| Ramila Diam Private Limited | ₹80.69 Cr (FY 2024) | 342.0% | Mumbai, Maharashtra, India | |||
| Shree Ram Ispat & Power Private Limited | ₹80.68 Cr (FY 2025) | 37.0% | Raipur, Chhattisgarh, India | |||
| G K Stones India Private Limited | ₹80.65 Cr (FY 2024) | 32.0% | Chennai, Tamil Nadu, India | |||
| Satna Abrasives Private Limited | ₹80.64 Cr (FY 2025) | 10.0% | Kolkata, West Bengal, India | |||
| Emmarlinkpharma Private Limitedthis company | ₹80.63 Cr (FY 2025) | ₹14.07 Lakh | 0.2% | 7.0% | Kannur, Kerala, India | |
| Nittu Creations Private Limited | ₹80.62 Cr (FY 2025) | 19.0% | Delhi, India | |||
| Linkpoint Advisory Private Limited | ₹80.62 Cr (FY 2019) | 294.0% | Kolkata, West Bengal, India | |||
| Konnark Polymer Private Limited | ₹80.6 Cr (FY 2025) | 4.0% | Thane, Maharashtra, India | |||
| Seyad Agro Industries Private Limited | ₹80.53 Cr (FY 2022) | 14.0% | Tirunelveli, Tamil Nadu, India | |||
| Silkflex Polymers (India) Limited | ₹80.51 Cr (FY 2025) | 59.0% | Howrah, West Bengal, India |
To see the full peer comparison of Emmarlinkpharma Private Limited, buy the company report.
Shareholding
The shareholding of Emmarlinkpharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Emmarlinkpharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.02 Cr
Satisfied charges
₹35.27 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 May 2024 | 100925375 | Axis Bank Limited | ₹9 Lakh | Satisfied | |
| 10 Jan 2024 | 100858586 | Dhanlaxmi Bank Limited | ₹6.75 Lakh | Satisfied | |
| 12 May 2022 | 100587048 | Axis Bank Limited | ₹2.25 Cr | Satisfied | |
| 07 Mar 2022 | 100574462 | Axis Bank Limited | ₹17.86 Cr | Satisfied | |
| 18 Aug 2021 | 100509436 | Others | ₹8.5 Cr | Satisfied |
To see the full charge records of Emmarlinkpharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Emmarlinkpharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.4 Cr; the latest was in March 2021.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹6.4 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2020 | Funding round | ₹6.4 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Emmarlinkpharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emmarlinkpharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Emmarlinkpharma has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAFCE4185N1ZD | Kerala | Active | 26 Dec 2019 |
| 32AAFCE4185N2ZC | Kerala | Active | 30 Jan 2020 |
| 32AAFCE4185N3ZB | Kerala | Active | 06 Jan 2021 |
To see the full GST registrations and return filing status of Emmarlinkpharma Private Limited, buy the company report.
Recent activity
Emmarlinkpharma Private Limited has 6 board changes on record since 2019: 5 appointments and 1 cessation. The latest: Ramakrishnan Makuni Varayil was appointed as Director on 24 Jan 2022.
Charges
A charge registered on 07 Mar 2022 via Charge ID 100574462 with Axis Bank Limited was fully satisfied on 19 Nov 2025.
Charges
A charge registered on 10 May 2024 via Charge ID 100925375 with Axis Bank Limited was fully satisfied on 04 Nov 2025.
Charges
A charge registered on 12 May 2022 via Charge ID 100587048 with Axis Bank Limited was fully satisfied on 18 Oct 2025.
Charges
A charge registered on 10 Jan 2024 via Charge ID 100858586 with Dhanlaxmi Bank Limited was fully satisfied on 10 Oct 2025.
AGM
Emmarlinkpharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Emmarlinkpharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.09 Cr with Charge ID 100925375 was registered on 10 May 2024.
Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100858586 was registered on 10 Jan 2024.
Charges
A charge with Axis Bank Limited of Rs. 17.86 Cr registered on 07 Mar 2022 with Charge ID 100574462 was modified on 05 Jul 2023.
Charges
A charge registered on 18 Aug 2021 via Charge ID 100509436 with Others was fully satisfied on 19 Jun 2023.
Charges
A charge registered on 28 Jul 2020 via Charge ID 100399315 with Others was fully satisfied on 19 Jun 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.25 Cr with Charge ID 100587048 was registered on 12 May 2022.
10 earlier events are in the company report.
Frequently asked questions
Emmarlinkpharma is an active private limited company based in Kannur, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 March 2019 (7+ years old) and is registered under CIN U74999KL2019PTC057236.
Emmarlinkpharma has 5 current directors:
- Ramakrishnan Makuni Varayil - Director
- Makkuni Amritha Ramakrishnan - Director
- Praveen Damodar - Director
- Aishwarya Praveen - Director
- Girija Ramakrishnan - Director
The latest financial statements of Emmarlinkpharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Emmarlinkpharma is 32AAFCE4185N1ZD, registered in Kerala. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 32AAFCE4185N2ZC (Kerala), 32AAFCE4185N3ZB (Kerala).
The CIN (Corporate Identification Number) of Emmarlinkpharma is U74999KL2019PTC057236. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emmarlinkpharma was incorporated on 19 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ernakulam.
Emmarlinkpharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.4 Cr; the latest was in March 2021.
The peers of Emmarlinkpharma by revenue are Abm International Limited, Ramila Diam Private Limited, Shree Ram Ispat & Power Private Limited, G K Stones India Private Limited, Satna Abrasives Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ramakrishnan Makuni Varayil was appointed as Director on 24 Jan 2022. Ramakrishnan Makuni Varayil ceased to be Director on 25 Jan 2021. Aishwarya Praveen was appointed as Director on 19 Mar 2019. Emmarlinkpharma has 6 board changes on record in total.
Yes, Emmarlinkpharma is registered as a medium enterprise under Udyam registration (number: UDYAM-KL-04-0009940).
Emmarlinkpharma can be reached through the website emmarlink.com. Its registered office is in Kannur, Kerala, India.